🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Luca Mologni

Azienda Ospedaliera San Gerardo

ORCID: 0000-0002-6365-5149

Also affiliated with University of Milano-Bicocca

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer”.

Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer

npj Precision Oncology(2025)10.1038/s41698-025-01088-0

N/A

0.208DataRank · unranked

3 citations

Nicoletta Cordani, Alberto Maria Villa, Federica Malighetti, Matteo Villa, Luca Sala +6 more

Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma

Blood(2021)10.1182/blood.2020008136

N/A

0DataRank · unranked

49 citations

Carmen Mecca, Qi Wang, Chiara Ambrogio, Inês Mota, Nina Prokoph +15 more

α‐Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML

ChemMedChem(2024)10.1002/cmdc.202400622

N/A

0DataRank · unranked

2 citations

Lorenza Destro, Luca Mologni, Valentina Crippa, Paolo Zardi, Francesco Fini +4 more